loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Forbaxin

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Granules Methocarbamol

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Forbaxin

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of April 17, 2024
    Enforcement Report - Week of April 17, 2024

    17 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf

    FDA
    17 Apr 2024
    Share Share
    Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection Due to Presence of White Particles
    Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection Due to Presence of White Particles

    28 Mar 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-fka-auromedics-pharma-llc-issues-voluntary-nationwide-recall-methocarbamol-injection

    FDA
    28 Mar 2024
    Share Share
    Mikart's Generic Methocarbamol Receives Approval in the U.S.
    Mikart's Generic Methocarbamol Receives Approval in the U.S.

    12 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212707

    FDA
    12 Jun 2023
    Share Share
    Lumirelax 10% cream: restrictions of use due to convulsions and allergic reactions
    Lumirelax 10% cream: restrictions of use due to convulsions and allergic reactions

    20 May 2022

    // Aude Lecrubier FRANCAIS

    https://francais.medscape.com/voirarticle/3608559

    Aude Lecrubier FRANCAIS
    20 May 2022
    Share Share
    Enforcement Report - Week of November 11, 2021
    Enforcement Report - Week of November 11, 2021

    10 Nov 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-11-2021-1636538960.pdf

    FDA
    10 Nov 2021
    Share Share
    Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Methocarbamol 500mg Bottles
    Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Methocarbamol 500mg Bottles

    18 Oct 2021

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bryant-ranch-prepack-issues-voluntary-nationwide-recall-methocarbamol-500mg-bottles-due-mislabeling

    FDA
    18 Oct 2021
    Share Share